Stay updated with breaking news from Beta Bionics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THURSDAY, Sept. 29, 2022 (HealthDay News) -- Reduction in glycated hemoglobin level is greater with use of a bionic pancreas compared with standard care in children and adults with type 1 diabetes, according to a study published in the Sept. 29 issue of the New England Journal of Medicine. Steven J. Russell, M.D., Ph.D., from
/PRNewswire/ -- Beta Bionics, Inc. — The results of the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial (IO BPPT), which were presented in...
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found.
The device controls blood sugar better than insulin shots while dramatically improving the patient's quality of life.
THURSDAY, Sept. 29, 2022 (HealthDay News) -- A new technology dubbed the "bionic pancreas" may beat standard treatment in helping people with type 1 diabetes control their blood sugar levels,